PDCD1 and non-small cell lung carcinoma: This study emphasized the factors influencing responses to PD-1/PD-L1 axis-targeting agents in NSCLC, including PD-L1 expression, TMB, interferon-associated mRNA expression profile (GEP), and the absence of liver metastases.